Close Menu

NEW YORK (GenomeWeb) — Abbott said today that its deal to acquire St. Jude Medical for $25 billion in cash and stock does not conflict with its previously announced acquisition to buy Alere, and that its financing plan contemplates the completion of both transactions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.